SCHENTAG JEROME J has a total of 14 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 1992. It filed its patents most often in EPO (European Patent Office), United States and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, medical technology and computer technology are MIVENION GMBH, FEHER JANOS and PARADIGM BIOPHARMACEUTICALS LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 4 | |
#2 | United States | 4 | |
#3 | WIPO (World Intellectual Property Organization) | 3 | |
#4 | China | 2 | |
#5 | Mexico | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Medical technology | |
#3 | Computer technology | |
#4 | Environmental technology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Diagnosis and surgery | |
#4 | Syringes | |
#5 | Healthcare informatics | |
#6 | Climate change adaptation technologies |
# | Name | Total Patents |
---|---|---|
#1 | Schentag Jerome J | 14 |
#2 | Mccourt Mary P | 9 |
#3 | Mielnicki Lawrence | 8 |
#4 | Hughes Julie | 5 |
#5 | D Andrea David T | 3 |
#6 | Bright Frank V | 2 |
#7 | Fayad Joseph M | 1 |
#8 | D'Andrea David T | 1 |
#9 | Mielnicki Lawrencee | 1 |
Publication | Filing date | Title |
---|---|---|
CN110418636A | Cholesteryl ester vesica peptide, protein and nucleic acid being loaded in chylomicron and body cell | |
EP3169331A1 | Activation of the endogenous ileal brake hormone pathway for organ regeneration and related compositions, methods of treatment, diagnostics, and regulatory systems | |
WO2014152795A2 | Cholestosome vesicles for incorporation of molecules into chylomicrons | |
US2013237774A1 | Device and Method for Continuous Chemical Sensing |